Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.61
Data as of Jan 28
 -0.12 / -6.94%
Today’s Change
0.97
Today|||52-Week Range
2.12
-14.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues10.7M597.7K78.7K1.1M
 
 
 
 
 
 
Operating ExpensesGross Income7.5M----393.6K
 
 
 
Total Operating Expenses17.0M24.7M28.1M39.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.3M-24.1M-28.0M-38.4M
 
 
 
 
 
Extraordinary Credit0.000.0032.1K0.00
 
 
Extraordinary Charge-43.1M-952.4K---1.5M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-49.9M-25.0M-29.2M-42.7M
 
 
 
 
 
Income Taxes0.00-7.9M0.000.00
 
 
Preferred Dividend-8.2M-100.0K-43.3K0.00
 
 
 
 
Net Income-50.0M-13.8M-29.2M-42.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS80.7M90.5M99.1M121.8M
 
 
 
 
 
Shares To Calculate EPS Diluted80.7M90.5M99.1M121.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.72$0.06-$0.29-$0.35
 
 
 
 
 
EPS Diluted----------
 

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.